ArticleBMC public health2025
"We have our reasons": Exploring the acceptability of pre-exposure prophylaxis among gay, bisexual, and other men who have sex with men in Ghana.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Where you live matters, but action is personal: insights from multilevel analysis of pre-exposure prophylaxis awareness, willingness, and use among men who have sex with men in China.Infectious diseases of poverty · 2026Article
- Pre-exposure prophylaxis against HIV infection among male population under perceived risk of sexually transmitted infections in Vojvodina, Serbia: a cross-sectional study on knowledge and attitudes.Frontiers in reproductive health · 2026Article
- Article
- Evaluating factors associated with awareness and attitude towards pre-exposure prophylaxis among cisgender sexually active women in Ghana.BMC public health · 2025Article
Corrections and comments
- Update of
Authors and funding
10 authors.
Funding
Abstract
backgroundGhanaian men who have sex with men (MSM) face significant HIV disparities compared to the general population in Ghana. Pre-exposure prophylaxis (PrEP) is a highly effective tool for HIV prevention. Previous studies on the perspectives of PrEP use among Ghanaian MSM identified high interest in PrEP among this population. However, the knowledge from the previous research, which was the best available evidence at the time, was primarily hypothetical because those data were collected before any real-world implementation of PrEP in Ghana. The analysis aims to identify and understand the factors currently influencing PrEP acceptance.
methodsWe analyzed focus group (n = 8) data with Ghanaian MSM. We transcribed, coded, identified, and analyzed the responses using descriptive thematic analysis.
resultsWe identified two broad themes. Under theme one, which indicated almost universal awareness of PrEP but inaccuracies about PrEP were common, these were the categories: (1) Awareness of PrEP and antiretroviral therapy [ART], (2) confusion between pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis, (3) event-driven perceptions of PrEP usage, (4) Mixed understanding of PrEP: distinguishing PrEP from ART, and (5) advocacy for a comprehensive educational approach. Theme two revealed that PrEP acceptability was influenced by a mix of individual and intrapersonal factors such as (1) hesitancy towards PrEP uptake due to perceived limited benefit, (2) extending HIV, sex, and same-gender sexual relations stigma to PrEP affects uptake, (3) perceived lack of information, concerns about side effects, and cost.
conclusionsTo bridge the gap between awareness, knowledge, and acceptability, HIV prevention programs should address access barriers and incorporate community-derived strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.